An Eight-Fold Risk? Reviewing the Evidence Behind the Testosterone Headline

EHS_Special-Release_Carrozzella_Jiang-Rebuttal

When a press release gets ahead of its own data, clinicians pay for it in the exam room. On October 20, The Menopause Society announced that testosterone therapy may increase cardiovascular risk in postmenopausal women. The release never confirms the women actually took testosterone, reports no doses or serum levels, and describes a study that hasn’t been peer reviewed. The authors themselves say it needs prospective investigation.

Our network asked us for a response. Dr. John Carrozzella, a member of our Medical Advisory Board, wrote one, and it’s thorough. Read it before your next patient asks.

Patients deserve choices built on good evidence. So do you.

Dr. Terri DeNeui, DNP, APRN, ACNP-BC Founder, EVEXIAS Health Solutions

Listen to my conversation with Dr. John Carrozzella here: The Dr. Terri Show